One of the primary limitations in cancer diagnostics is the sensitivity and specificity of current detection methods. Traditional techniques like biopsies and imaging are often invasive, costly, and may not detect cancer at its earliest stages. Moreover, biomarker discovery is still in its infancy, making it challenging to identify unique markers that could reliably indicate the presence of different cancer types.
